Gebelikte farklı glikoz tolerans derecelerinin adipositokinler ile iliskisi
Thesis Type: Expertise In Medicine
Institution Of The Thesis: İstanbul Üniversitesi, Istanbul Medical Faculty, Department of Medical Biochemistry, Turkey
Approval Date: 2010
Thesis Language: Turkish
Student: Tülin İşkurt Saraç
Principal Supervisor (For Co-Supervisor Theses): AYŞE GÜL SÜNDÜS TELCİ
Open Archive Collection: AVESIS Open Access Collection
Abstract:Gestational diabetes mellitus (GDM) is defined as glucose intolerance that appears or is first recognized during pregnancy and resolves with delivery. Being the most frequent metabolic complication of pregnancy, GDM is associated with increased risks of adverse obstetrical outcomes and developing type 2 diabetes in the years following the index pregnancy. Depending on the population studied, 1 to 14% of all pregnancies are complicated by GDM.Human pregnancy is characterised by a series of metabolic changes that promote the development of insulin resistance to optimise fetal nutrition. Normal pregnancy is associated with a progressive decline in insulin sensitivity, and GDM develops at the end of the second trimester during which insulin resistance is at its maximum.It is important that GDM is diagnosed clinically, so that the potential complications are prevented. Therefore, pregnant women are screened for GDM by oral glucose tolerance test (OGTT) in late second trimester to determine the group under risk.In Turkey, gestational diabetes screening is performed between 24-28 weeks, following a two-step approach. The screening glucose challenge test (GCT) involves drinking a solution containing 50 g of glucose, and measuring blood glucose level 1 hour later. If blood glucose level exceeds 140 mg/dL, diagnostic 3-hour oral glucose tolerance test with 100 g of glucose is performed. Gestational diabetes mellitus is diagnosed by two or more abnormal glucose values on 3-h OGTT.It has long been recognized that GDM is associated with an increased risk of subsequent type 2 diabetes. However, it has recently emerged that women who have a pregnancy complicated by an abnormal GCT, but who do not have GDM and accepted as having normal glucose tolerance (NGT), are at incrased risk of subsequent diabetes, compared with their peers with a normal GCT.Underlying mechanisms of insulin resistance in pregnancy and pregnancy disorders are not fully understood. Recent investigations have focused on several new potential mediators of insulin resistance, including adipose tissue-derived hormones, called adipocytokines, including leptin, adiponectin, tumor necrosis factor ? (TNF-?), interleukin 6 (IL-6), and the newly discovered resistin and visfatin. Besides regulating maternal energy metabolism and insulin sensitivity in normal pregnancy, adipocytokines have been implicated in pregnancy complications such as GDM.Various studies investigating adipocytokine levels in normal and GDM complicated pregnancies have yielded contradictory results. Adipocytokine levels of pregnant women whose screening test results are abnormal but not diagnosed as GDM, and accepted as having normal glucose tolerance (NGT) have not been investigated.In conclusion, adiponectin, leptin, resistin and visfatin levels of the pregnant women in the BGT group who had mild dysglycemia were much like those of the GDM group, rather than the NGT group. It has been reported that even in the absence of GDM, women with an abnormal GCT in pregnancy have a significantly increased risk of developing diabetes in the years following the pregnancy. However, this group of at-risk young women are not recognized and do not receive any follow-up after the pregnancy. Our data support the hypothesis that these women may benefit from postpartum surveillance and diabetes prevention strategies.